Cargando…
Preserved SARS-CoV-2 Vaccine Cell-Mediated Immunogenicity in Patients With Inflammatory Bowel Disease on Immune-Modulating Therapies
Immune-modulating medications for inflammatory bowel diseases (IBDs) have been associated with suboptimal vaccine responses. There are conflicting data with SARS-CoV-2 vaccination. We therefore assessed SARS-CoV-2 vaccine immunogenicity at 2 weeks after second mRNA vaccination in 29 patients with IB...
Autores principales: | Boland, Brigid S., Goodwin, Benjamin, Zhang, Zeli, Bloom, Nathaniel, Kato, Yu, Neill, Jennifer, Le, Helen, Tysl, Tiffani, Collins, Angelina E., Dulai, Parambir S., Singh, Siddharth, Nguyen, Nghia H., Grifoni, Alba, Sette, Alessandro, Weiskopf, Daniela, Chang, John T., Dan, Jennifer M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9038482/ https://www.ncbi.nlm.nih.gov/pubmed/35347100 http://dx.doi.org/10.14309/ctg.0000000000000484 |
Ejemplares similares
-
Tu1552: PRESERVED SARS-COV-2 VACCINE CELL-MEDIATED IMMUNOGENICITY IN INFLAMMATORY BOWEL DISEASE PATIENTS ON IMMUNEMODULATING THERAPIES
por: Boland, Brigid S., et al.
Publicado: (2022) -
Biomarkers are associated with clinical and endoscopic outcomes with
vedolizumab treatment in Crohn’s disease
por: Holmer, Ariela K., et al.
Publicado: (2020) -
SARS-CoV-2 vaccination induces immunological T cell memory able to cross-recognize variants from Alpha to Omicron
por: Tarke, Alison, et al.
Publicado: (2022) -
Predicting HLA CD4 Immunogenicity in Human Populations
por: Dhanda, Sandeep Kumar, et al.
Publicado: (2018) -
Humoral and cellular immune memory to four COVID-19 vaccines
por: Zhang, Zeli, et al.
Publicado: (2022)